Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.

Background: The management of steroid-resistant glomerulopathies remains a clinical problem. In this trial, we report a clinical observation of 43 patients treated with mycophenolate mofetil (MMF) for steroid-resistant glomerulopathies.

Methods: All patients underwent renal biopsies, and immunofluorescence and light microscopy examinations were conducted in all cases.